Patent Assignment
Reel/Frame 061607/0519
Assignment of Assignor's Interest
Recorded: 2022-11-01
Pages: 15
Assignors
BUCK, ELIZABETH
Executed: 2022-10-13
O'CONNOR, MATTHEW
Executed: 2022-10-13
ROMASHKO, DARLENE
Executed: 2022-10-08
LIN, TAI-AN
Executed: 2022-10-13
WRONA, IWONA
Executed: 2022-10-12
LUCAS, MATTHEW C.
Executed: 2022-10-13
ROBERTS, CHRIS
Executed: 2022-10-13
SMITH, SHERRI
Executed: 2022-10-12
WATERS, NIGEL
Executed: 2022-10-13
Assignee
BLACK DIAMOND THERAPEUTICS
ONE MAIN STREET, 10TH FLOOR, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(6)
Method of Treating Cancers with Alkyne Substituted Quinazoline Derivatives
Application:
63/108,645 →
Method of Treating Cancers with Alkyne Substituted Quinazoline Derivatives
Application:
63/166,045 →
Method of Treating Cancers with Alkyne Substituted Quinazoline Derivatives
Application:
63/190,067 →
Method of Treating Cancers with Alkyne Substituted Quinazoline Derivatives
Application:
63/218,717 →
Method of Treating Cancers with Alkyne Substituted Quinazoline Derivatives
Application:
63/237,782 →
Method of Treating Cancers with Alkyne Substituted Quinazoline Derivatives
Application:
63/244,540 →
PCT:
PCT/US2021/057724 ↗
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 1, 2022
From: RIDGELINE THERAPEUTICS GMBH
To: BLACK DIAMOND THERAPEUTICS
Reel/Frame 061607/0567 →
Assignment of Assignor's Interest
Nov 1, 2022
From: FLOHR, ALEXANDER; ARISTA, LUCA; OTTAVIANI, GIORGIO
To: RIDGELINE THERAPEUTICS GMBH
Reel/Frame 061607/0534 →
Corrective Assignment to Correct the Assignee's Name Previously Recorded at Reel: 061607 Frame: 0519. Assignor(S) Hereby Confirms the Assignment.
Sep 6, 2023
From: BUCK, ELIZABETH; O'CONNOR, MATTHEW; ROMASHKO, DARLENE; LIN, TAI-AN
To: BLACK DIAMOND THERAPEUTICS, INC.
Reel/Frame 064819/0168 →
Corrective Assignment to Correct the Assignee Name Previously Recorded on Reel 061607 Frame 0567. Assignor(S) Hereby Confirms the Assignment.
Sep 6, 2023
From: RIDGELINE THERAPEUTICS GMBH
To: BLACK DIAMOND THERAPEUTICS, INC.
Reel/Frame 064819/0223 →
Assignment of Assignor's Interest
Apr 8, 2025
From: EPSTEIN, DAVID M.
To: BLACK DIAMOND THERAPEUTICS, INC.
Reel/Frame 070772/0793 →